Adulteration

Getty Images

Guest article

ONHA’s view: Don’t let strong sales in 2019 obscure important issues

By Karen Howard, CEO and Executive Director of Organic & Natural Health Association

Successful evaluation of the progress or travails of 2019 requires more than measuring growth in dietary supplements sales, which by that measure alone indicates we had a banner year.

Getty Images

Guest article

CBD, climate crisis, sustainability: ABC takes a look at 2019 and beyond

By Stefan Gafner and Mark Blumenthal, American Botanical Council

The news about CBD and hemp extracts dominated 2019, says the American Botanical Council. But issues surrounding the ongoing climate crisis, questions of sustainability, and the ongoing questions of adulteration were important topics as well.

Getty Images

Guest article

The legacy of 2019: CBD, mandatory listing and discord

By Steve Mister, President & CEO, Council for Responsible Nutrition

The question of CBDs, and of a mandatory product listing, have dominated a year that for the dietary supplement industry has not been as tumultuous as some.

FDA photo

Editor's Spotlight

FDA needs new tools in face of CBD explosion, official says

By Hank Schultz

FDA needs new tools to effectively deal with an expanding supplement marketplace, according to agency official Lowell Schiller. This is especially true when contemplating the flood of CBD products, with many more yet to come.

NutraIngredients-USA photo

BAPP’s adulterated materials SOP nearing final form

By Hank Schultz

The Botanical Adulterants Prevention Program is nearing the final stage of its initiative to offer industry a way to keep adulterated materials from turning up in finished goods on the shelf.

Follow us

Featured Events

View more

Products

View more

Webinars